**The cancer clock is ticking - A ray of hope in the fight against tumors and metastases**

Every year, over 600,000 people in Germany are diagnosed with cancer. Statistically, most people die from pancreatic cancer, lung cancer, breast cancer, bowel cancer, prostate cancer, glioblastoma, etc. Common therapeutic measures such as surgery, radiotherapy and chemotherapy are the gold standard in treatment. However, immunotherapy is becoming increasingly important to counteract these diverse challenges. However, it is important to know that not every immunotherapy is equally valuable. Some forms of treatment are associated with significant side effects, which in the worst case can even be fatal.

One promising development is individualized immunotherapies that are produced from the blood of affected patients. These individualized approaches offer the advantage of minimizing rejection reactions and serious side effects. In fact, over 70% of cancer patients can receive the redemptive news that they have been cured of cancer after five years. The primary tumor has been successfully treated with surgery, chemotherapy or tailored immunotherapies.

However, scientific studies show that the biggest problem often lies not in the treatment of the primary tumors, but in the metastases that can form in the body. These metastases often grow unnoticed and are often only detected late. They have the potential to break away from the original tumor, disrupting the natural cell death process known as apoptosis. Up to 350,000 mutations can occur in the genome, allowing the cancer cell to grow unhindered and rapidly. Statistics show that most cancer deaths occur between the 6th and 8th year after initial diagnosis, often triggered by metastases detected at this time. By then it may be too late, and the traditional treatment approaches often lose their effect.

Fortunately, progress has now been made in the form of blood tests that measure the number of living and dead tumor cells. These tests provide information on how many active tumor cells are present in the body and whether conventional therapies still have a chance of success. Unfortunately, such tests are often expensive and are not always offered by oncologists, as standard therapies are more cost-effective. In addition, genetic tests can cost up to 6,000 euros, even though they can help to treat the tumor in a targeted manner and significantly increase the chances of success.

Another innovative approach is tumor antigen-loaded dendritic cell therapy. Dendritic cells act as guard cells of the immune system. They recognize foreign structures - such as bacteria, viruses and malignant cells - and are crucial in the fight against tumours and metastases. Scientists agree that only our own immune system is capable of ridding itself of tumors and metastases.

Quality of life is a key aspect for many cancer patients. Dendritic cell therapy, which is produced from the patient's blood on an outpatient basis, has hardly any side effects, prevents rejection reactions and can be used in combination with other therapeutic measures. This opens up new perspectives for effectively combating tumors and metastases.

To find out whether immunotherapy with tumor antigen-loaded dendritic cells has any prospect of therapeutic success for your specific cancer, you can consult immunologists or complementary medicine specialists. There are over 200,000 studies on 200 different types of cancer worldwide, providing valuable insights. Let's use this glimmer of hope together in the fight against cancer.

IMMUMEDIC Limited
Bessemerstrasse 82 10 OG Süd
12103 Berlin
Germany

https://www.dendritische-zelltherapie-deutschland.com/impressum

Herr Andreas
03022078743

immumedic@gmail.com

In modern medicine, we face major challenges, especially in the treatment of cancer and autoimmune diseases. Many conventional therapies are often associated with numerous side effects and do not always provide the desired results. Patients are looking for effective solutions that not only alleviate the symptoms but also address the underlying causes. The search for a suitable therapy can be frustrating and overwhelming.Imagine how many people suffer from the consequences of cancer or autoimmune diseases - they experience not only physical pain, but also psychological stress due to uncertainty and anxiety. Patients often feel powerless in the face of their diagnosis. For 10 years, we have been at the side of our customers, doctors, practices, clinics and patients with our services and have been able to help many to fight not only the primary tumor but also the metastases.

This release was published on openPR.